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Abstract Objective: To study the types and incidence of chromosomal abnormal-
ities in infertile men with azoospermia and severe oligozoospermia in Qatar, and
to compare the hormonal changes, testicular sperm retrieval rate, and intracytoplas-
mic sperm injection (ICSI) outcome between patients with chromosomal abnormal-
ities and patients with idiopathic infertility.
Patients and methods: This study involved the retrospective chart review of 625
infertile male patients attending an academic tertiary medical centre in Qatar.
Retrieved information included data on medical history, family history, clinical
examination, semen analysis, initial hormonal profiles, and genetic studies, ICSI,
and sperm retrieval results.
Results: The incidence of chromosomal abnormalities was 9.59% (10.6%
amongst Qatari patients, 9.04% amongst non-Qataris). About 63.6% of the sample
had azoospermia, of whom 10.8% had chromosomal abnormalities. Roughly 36.4%
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of the sample had oligozoospermia, of whom 7.5% had chromosomal abnormalities.
There were no differences between patients with chromosomal abnormalities and
those with idiopathic infertility for demographic and infertility features; but for
the hormonal profiles, patients with idiopathic infertility had significantly lower
luteinising hormone and follicle-stimulating hormone values. For ICSI outcomes,
patients with chromosomal abnormalities had a significantly lower total sperm
retrieval rate (47.4% vs 65.8%), surgical sperm retrieval rate (41.2% vs 58.1%),
and lower clinical pregnancy rate (16.7% vs 26.6%) when compared to the idio-
pathic infertility group.
Conclusion: The incidence of chromosomal abnormalities in Qatar as a cause of
severe male infertility is within a similar range as their prevalence internationally.
 2017 Production and hosting by Elsevier B.V. on behalf of Arab Association of
Urology. This is an open access article under the CC BY-NC-ND license (http://
creativecommons.org/licenses/by-nc-nd/4.0/).
Introduction
Infertility, defined as the inability to conceive after at
least 1 year of regular unprotected intercourse, is a
major health challenge affecting >186 million couples
worldwide [1]. In the USA, 10–15% of couples attempt-
ing to conceive are infertile, with male factors contributing
to 50% of such cases [2]. Amongst the several causes
of male factor infertility, genetic causes play an impor-
tant role with a reported incidence of 2–8% in infertile
men, increasing to 19% in men with azoospermia [3].
Chromosomal abnormalities are mainly found in
cases of severe testicular impairment: azoospermia and
severe oligozoospermia. Such abnormalities can be
numerical and/or structural. The most common numer-
ical genetic abnormality is Klinefelter syndrome (KS),
with 5% and 10% prevalence in men with severe oligo-
zoospermia and azoospermia, respectively [4]. It is char-
acterised by the presence of an extra X chromosome
leading to severe testicular dysfunction, failure of sper-
matogenesis, and hypergonadotrophic hypogonadism.
Structural genetic abnormalities include chromosomal
translocations (Robertsonian or reciprocal), inversions,
and Y chromosome microdeletions (YCMD).
The study of the genetics of male infertility became
more important in the past few decades with the advent
of intracytoplasmic sperm injection (ICSI) in 1992.
Infertile patients with severe oligo/azoospermia became
capable of fathering their biological children [5]. How-
ever, using ICSI in this group of patients with a high
genetic abnormality ratio could lead to increased risk
of inheritance of genetic disorders to offspring, or the
evolution of novel genetic disorders [5]. In addition,
such chromosomal abnormalities may adversely affect
the outcome of pregnancy, with a higher incidence of
spontaneous abortion than amongst men with normal
genetic assays [6]. Patient counselling, together with
the possibility of using pre-implantation genetic diagno-
sis prior to ICSI should be offered to infertile patients
with chromosomal abnormalities.
The literature on genetic causes of male factor infer-
tility reveals several gaps, and our understanding of this
issue remains limited [7]. Generally, there are few studies
with a primary focus on the association of hormonal
profile changes in infertile men with chromosomal
abnormalities [8]. In addition, there is a noticeable lack
of research of the chromosomal abnormalities in male
infertility in the Middle East and North Africa region
(MENA), with some rare exceptions in some countries
of Northern Africa e.g. Morocco, Tunisia, and Jordan
[9,10], but with no studies from Arabian Gulf area. This
is despite that the MENA exhibits a unique social port-
folio characterised by a high prevalence of consan-
guineous marriages amongst their populations,
commonly driven by ethnic or tribal considerations
[11]. In some countries, up to two-thirds of marriages
are between cousins, causing an increase in the incidence
of recessive disorders [12]. Indeed, high consanguinity
rates along with their role in the occurrence of genetic
diseases are witnessed across the MENA. For instance,
amongst Palestinian Arabs, 44.3% of marriages are
between relatives (22.6% between first cousins) [13]; in
Morocco, the consanguinity prevalence was 15.25%
[14]; and, in Jordan about 20–30% of all marriages were
between first cousins [15].
Moreover, the young age of consanguineous mar-
riage seen in these countries increases the risk of
chromosomal disorders [1–3]. The State of Qatar, in
many aspects, is characteristic of the MENA in terms
of the high preference for consanguineous unions
(51%), and first-cousin marriages comprise 26.7%
of all marriages [16]. Such high ‘inbreeding’ could
ultimately lead to an increase in homozygous reces-
sive disorders, both known and novel, affecting some
reproductive and developmental health parameters,
and consequently resulting in infertility related disor-
ders [17].
Therefore, to bridge this knowledge gap, the present
study of infertile male patients attending an academic
tertiary medical centre in Qatar, assessed:
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(i) the types and incidence of chromosomal abnormalities
(across patients with azoospermia and severe oligo-
zoospermia, and by nationality);
(ii) a range of demographic (age, spouse age), infertility
(type, duration), and hormonal (oestradiol, LH, FSH,
prolactin, testosterone) profiles of infertile patients in
association with chromosomal abnormalities compared
with those with idiopathic infertility;
(iii) Sperm retrieval rate (across whole sample and by genetic
abnormality); and
(iv) ICSI outcomes amongst patients with chromosomal
abnormalities and those with idiopathic infertility
To the best of our knowledge, this is the first study in
Qatar and across the Arabian Gulf region, and one of
the very few in the MENA to conduct such a detailed
genetic, hormonal, sperm retrieval and ICSI outcomes
undertaking.
Patients and methods
Ethics, sample and procedures
This retrospective chart review was undertaken at the
Male Infertility Unit of the largest tertiary hospital in
Qatar, where we searched, retrieved and reviewed the
medical records of all patients attending the Unit
between January 2008 and January 2012. The study
was approved by the Institutional Review Board (Proto-
col #11,251/11). Inclusion criteria included male infertile
patients who had semen analysis showing azoospermia
or severe oligozoospermia (<5  106 sperm/mL), and
who had performed genetic studies (karyotyping and
YCMD assay). Out of the 625 records reviewed, 511
patients met the inclusion criteria. The clinical data col-
lected from the medical records included medical his-
tory, family history, and clinical examination. In
addition, semen analysis information, initial hormonal
profiles, findings of the genetic studies, ICSI data, and
sperm retrieval results were also noted.
Semen analysis and hormonal profile
Semen analysis was undertaken according to fifth edi-
tion of WHO manual for examination and processing
of human semen 2010 [18]. Each patient’s baseline hor-
monal profile (i.e. before receiving any treatment) was
documented, including FSH (1–19 IU/L), LH (1–9 IU/
L), prolactin (73–407 mIU/L), total testosterone (10.4–
35 nmol/L), and oestradiol (73–275 pmol/L).
Genetic investigations
Cytogenetic investigations were performed on the
patient’s chromosomes obtained from peripheral blood
lymphocytes, which were cultured in Roswell Park
Memorial Institute (RPMI) medium 1640 (Gibco, Invit-
rogen Carlsbad, CA, USA), phytohemagglutinin
(Shanghai Yihua Medical Technology Co., Ltd., Shang-
hai, China), and foetal bovine serum (Beijing Dingguo
Biotechnology, Beijing, China) for 72 h, followed by
treatment with 50 lg/mL colcemid. Metaphase chromo-
some spreads were studied by standard GTG and CBG
banding procedures, which included using trypsin and
Giemsa for G-banding and barium hydroxide for C-
banding. FISH was performed on 30 metaphase chro-
mosome spreads using a mixture of probes specific for
X centromere a-satellite (DXZ1) and Y centromere a-
satellite (DYZ3; CSP X spectrum green and CSP Y
spectrum red; Beijing GPMedical Technologies, Beijing,
China), and a chromosome-specific probe for core-
binding factor b subunit (CBFB, GLP 16 banding at
16q22, spectrum red; Beijing GP Medical Technologies).
Multiplex PCR amplification of nine sequence-tagged
site markers was used to detect azoospermia factor
(AZF) region for YCMD [19].
Statistical analysis
Statistical analyses were undertaken using the Statistical
Package for the Social Sciences (SPSS version 19.0;
IBM Corp., Armonk, NY, USA), with significance set
at P< 0.05. Descriptive statistics (frequencies and per-
centages) were used to summarise the patients’ demo-
graphic and clinical characteristics. The paired t-test
compared means of all quantitative variables measured
between the two studied groups (patients with idiopathic
infertility and patients with chromosomal abnormali-
ties). For categorical variables, the chi-squared test
examined the associations between the different param-
eters with the outcome. In cases where the assumptions
of the parametric test were not fulfilled, then either suit-
able data transformation or the corresponding non-
parametric test was used to assess the impact of different
factors on outcome.
Results
The sample comprised 511 patients, of which 179
(35.03%) patients were Qatari nationals, and the
remaining 332 (64.97%) patients were of other national-
ities (Arab and non-Arab countries). Azoospermia was
diagnosed in 325 patients (63.6%), and severe oligo-
zoospermia in 186 patients (36.4%). Based on the
genetic findings, patients were categorised into two
groups: those with chromosomal abnormalities and
those with idiopathic infertility.
Across the whole sample, the incidence of chromoso-
mal abnormalities was 9.59% (49/511 patients). Of the
179 Qatari patients, the incidence of chromosomal
abnormalities was 10.6% (19/179 patients), whilst the
incidence of chromosomal abnormalities amongst non-
Qatari patients was 9.04% (30/332 patients). Chromosomal
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abnormalities were found in 10.78% of the azoospermia
group (35/325 patients) compared to 7.5% of the
oligozoospermia group (14/186 patients).
Table 1 depicts the frequencies of each chromosomal
abnormality in each of the azoospermia and severe
oligozoospermia groups, as well as amongst Qatari
and non-Qatari patients. Across the whole sample, for
azoospermia patients, KF was the most common chro-
mosomal abnormality followed by YCMD. For the sev-
ere oligozoospermia group, YCMD was the most
common chromosomal abnormality followed by
Robertsonian translocations. By nationality, generally,
Qatari nationals exhibited a higher prevalence of KF
(amongst the azoospermia group) and YCMD (amongst
the severe oligozoospermia group) than non-Qataris.
Table 2 shows the detailed chromosomal abnormalities
of the patients.
Table 3 shows the characteristics of patients with
chromosomal abnormalities vs those with idiopathic
infertility across the whole sample and amongst the
oligozoospermia patients. For the total sample, there
were no differences between patients with chromosomal
abnormalities and those with idiopathic infertility for
demographic and infertility features. However, when
comparing the hormonal profiles, patients with idio-
pathic infertility had significantly higher oestradiol and
significantly lower LH and FSH values.
Table 4 shows the ICSI outcomes amongst patients
with chromosomal abnormalities and patients with idio-
pathic infertility. Only 38 of the 49 patients with chro-
mosomal abnormalities underwent a trial of ICSI.
Sperm were successfully retrieved in 18 patients [four
cases from semen; 14 cases from testis (14/34 patients,
surgical sperm retrieval (SSR) rate = 41.2%)]. Of the
462 patients with idiopathic infertility, 234 patients
underwent ICSI trial. Sperm was successfully retrieved
in 154 patients [43casesfromsemen;111casesfromtestis(1
11/191patients,SSRrate = 58.1%)]. The chromosomal
abnormalities group had a significantly lower total
sperm retrieval rate (47.4% vs 65.8%), SSR rate
(41.2% vs 58.1%), and lower clinical pregnancy rate
(16.7% vs 26.6%) when compared to the idiopathic
infertility group. All three clinical pregnancies reported
in the chromosomal abnormalities group were amongst
patients with KS. Table 5 shows the sperm retrieval rate
for each genetic abnormality.
Discussion
We assessed the types and incidence of chromosomal
abnormalities amongst infertile men presenting to the
largest tertiary medical centre in Qatar, and explored
the outcomes of ICSI in these abnormalities. Overall,
9.59% of our present sample had a chromosomal abnor-
mality. A significantly lower sperm retrieval rate and
ICSI pregnancy outcomes were seen amongst our infer-
tile patients with chromosomal abnormalities than
amongst our patients with idiopathic infertility.
Numerous chromosomal abnormalities exist, where
about one in 150 babies is born with a numerical or
Table 1 Chromosomal abnormalities amongst patients with azoospermia and severe oligozoospermia.
Abnormality Azoospermia, n Severe oligozoospermia, n
Qatari
n= 119
Non-Qatari
n= 206
Total
n= 325
Qatari
n= 60
Non-Qatari
n= 126
Total
n= 186
KS 12 6 18 1 0 1
Robertsonian translocation 1 2 3 0 3 3
Reciprocal translocation 1 3 4 1 1 2
YCMD 2 5 7 0 6 6
Other chromosomal abnormalities 0 3 3 1 1 2
Total (%) 16 (13.5) 19 (9.2) 35(10.7) 3 (5) 11 (8.7) 14 (7.5)
Table 2 Chromosomal abnormalities detected across the
whole sample.
Genetic
abnormality
Description Patients,
n
Chromosomal
KS 47 XXY (non-mosaic) 19
Robertsonian
translocation
45XY, der(14;15)(q10;q10); 45XY,
der(14;21)(q10;q10)
45XY, der(13;14)(q10;q10); 45XY,
der(13;14)(q10;q10)
45XY, der(15;21)(q10;q10); 45XY,
der(13;14)(q10;q10)
6
Reciprocal
translocation
46XY, t(11;19)(p10;p10); 46XY, t
(5;6)(p10;q10); 46XY, t(2;9)(p21;
p22)
46XY, t(2;4)(P11.2;q31.3); 46XY,
t(Y;10)(q11.2; q24);
46XY, t(11;22)(p10;q10)
6
Other (sex
chromosome
aberrations)
45XO/46XY; MOS 47XY
(Marker 11)/ 46XY (Marker 10)
46XX (X-Y translocation); mos
45X[7]/ 46XY[43]
46XY, Inv(9)(p13;q21.1)
5
YCMD AZFb and c microdeletion 5
AZFa microdeletion 1
AZFc microdeletion 7
Total YCMD 13
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structural chromosomal abnormality [20]. Whilst most
abnormalities are detected early in life due to apparent
phenotypic anomalies, a good percentage may not
impact the patients’ health, particularly when no genetic
material is missing or duplicated. In such cases, the
indolent effect of the genetic aberration may be detected
later in life. Male infertility is one such example, where
the effect of inherent chromosomal anomalies cannot
be known prior to adulthood. Epidemiological studies
have reported an inverse relationship between the inci-
dence of chromosomal abnormalities and the severity
of male infertility, with rates reaching up to 19% in
infertile men with azoospermia [3]. In the present study,
the percentage of chromosomal abnormalities amongst
infertile men with severe oligozoospermia and azoosper-
mia was 7.5% and 10.7%, respectively. The most fre-
quent chromosomal anomalies we observed were sex
chromosome abnormalities, where KS was most fre-
quent (3.7%), followed by YCMD (2.5%), and then
autosomal translocations (2.3%).
Our present observed incidence of chromosomal
abnormalities falls within previously conveyed rates
from the region. A study in Morocco evaluated 444
azoospermic and 129 oligozoospermic men for the pres-
ence of chromosomal abnormalities to report an overall
incidence of 10.5%, where 41 (7.1%) patients had KS,
16 (2.7%) had YCMD, and four (0.7%) had autosomal
abnormalities [9]. Likewise, in Tunisia (401 infertile men
with non-obstructive azoospermia), the overall inci-
dence of chromosomal abnormalities was 12.22% [10];
and in Iran (222 men with infertility) the incidence of
chromosomal abnormalities was 13.9% [21].
Chromosomal abnormalities contribute to infertility
by influencing a variety of physiological processes
including hormonal homoeostasis, spermatogenesis,
and sperm quality. Therefore, an understanding of the
genetic basis of reproductive failure is essential to not
only understand the possible cause of infertility, but to
also appropriately manage an infertile couple.
A variable degree of hypothalamic–pituitary–gonadal
axis disruption can be expected to occur with chromoso-
mal abnormalities. KS represents a typical example of
hypergonadotrophic hypogonadism that occurs sec-
ondary to testicular failure; Kallmann syndrome, on
Table 3 Characteristics of infertile patients with chromosomal abnormalities and idiopathic infertility.
Variable Infertile patients P
Chromosomal abnormalities Idiopathic infertility
Total sample, n 49 462
Demography, mean (SD)
Age, years 34.5 (9.5) 35.5 (8.2) 0.24
Wife’s age, years 28.3 (6.5) 28.6 (6.3) 0.43
Infertility features
Type, n
Primary 47 411
Secondary 2 51
Duration, years, mean (SD) 5.4 (4.8) 5.6 (5.7) 0.56
Baseline hormone profile, mean (SD)
Oestradiol, pmol/L 96 (45.2) 152.6 (740.1) 0.001
LH, IU/L 9.6 (7.3) 5.7 (5.8) 0.001
FSH, IU/L 16.1 (12.8) 9.7 (9.5) 0.001
Prolactin, mIU/L 341.5 (195.3) 277.3 (170.5) 0.5
Testosterone, nmol/L 11.02 (5.97) 15.55 (7.98) 0.11
Oligozoospermia group, mean (SD)
Sperm count, million/mL 0.38 (1.1) 0.88 (1.8) 0.12
Total sperm motility,% 5.7 (3.8) 3.8 (2.8) 0.1
Table 4 ICSI outcomes amongst infertile patients with chromosomal abnormalities and those with idiopathic infertility.
Parameter Total, n/N (%)
N= 272
Infertile patients, n/N (%) P
Chromosomal abnormalities
n= 38
Idiopathic infertility
n= 234
Sperm retrieved from semen 47 4 43
SSR 125/225 (55.5) 14/34 (41.2) 111/191 (58.1) 0.023*
Total sperm retrieval 172/272 (63.2) 18/38 (47.4) 154/234 (65.8) 0.001*
Pregnancy outcome 44/171 (25.7) 3/18 (16.7) 41/154 (26.6) 0.001*
*P< 0.05.
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the other hand, impairs gonadotrophin secretion result-
ing in a state of hypogonadotrophic hypogonadism [22].
Few studies have assessed the hormone status of infertile
men with chromosomal abnormalities. Our present
study found significantly higher FSH, LH, and oestra-
diol levels amongst infertile patients with chromosomal
abnormalities in comparison to those with idiopathic
infertility; and whilst the serum testosterone level was
lower in men with chromosomal abnormalities, the dif-
ference did not reach statistical significance. In agree-
ment with our present findings, a study of the
influence of chromosomal abnormalities on reproduc-
tive hormone levels (691 infertile vs 78 fertile men) by
Elfateh et al. [8] reported chromosomal abnormalities
amongst 83 men (12.01%) in the infertile group. The
authors also found significantly lower testosterone levels
and testosterone/LH levels amongst infertile patients
with chromosomal abnormalities compared with fertile
men (P< 0.001 for all) [8]. Moreover, significantly
higher FSH and LH levels were detected in men with
KS (both P= 0.001), Robertsonian translocations (P
= 0.08 and P= 0.007), chromosome polymorphisms
(P 0.001 and P= 0.002) and YCMD (both P<
0.001); whilst patients with reciprocal translocations
had only significantly higher LH levels (P= 0.03) [8].
Others compared the hormone levels of 33 infertile
men with chromosomal abnormalities and 139 infertile
men with no known chromosomal abnormalities, and
detected significantly higher FSH and LH levels (both
P< 0.001), and significantly lower testosterone levels
(P= 0.004) amongst the infertile men with chromoso-
mal abnormalities [23].
The advent of ICSI emphasises the need to acknowl-
edge the role of genetics in male factor infertility because
it enables men with sub-optimal sperm quality to over-
come natural selection mechanisms and produce a viable
zygote [4]. Nonetheless, the frequencies of mutations
that may be inherited through these procedures and
their impact on future generations are not yet fully
understood. Furthermore, chromosomal abnormalities
may in fact offer prognostic information on the sperm
retrieval rates of men undergoing testicular sperm
extraction (TESE) and their ICSI outcomes [24,25]. In
agreement with such findings, our present study found
significantly lower sperm retrieval rate amongst infertile
patients with abnormal genetics compared to those with
normal genetics.
The Y chromosome contains many genes that are
critical for spermatogenesis and development of male
gonads, and YCMD are major causes of severe male
factor infertility [26]. A particular area of interest on
the Y chromosome is the AZF region. Molecular map-
ping analyses of patients with YCMD revealed three
non-overlapping regions of the Y chromosome (AZFa,
AZFb, and AZFc), and their deletion significantly alters
spermatogenesis causing primary testicular insufficiency
[27]. About 60% of YCMD occur in AZFc, 15% occur
in AZFb, and 5% in AZFa. The other 20% involve
more than one AZF region [28]. AZFa, AZFb or
AZFa/b microdeletions are associated with the worst
prognosis for sperm retrieval. Although previously
sperm retrieval in AZFa and b cases were thought to
be deemed to failure [29], recent studies have reported
sperm recovery from a few such cases [30]; whereas
patients with AZFc and AZFb/c microdeletions have a
SSR rate of 54.8% and 7.1%, respectively [29]. More-
over, AZFc patients are not necessarily azoospermic,
and may be candidates for ICSI using sperm from their
ejaculate. In the present study, no sperm could be
retrieved from cases with combined AZFb and c dele-
tions. Of our five AZFc deletion patients who under-
went ICSI, two provided sperm from ejaculate and
three underwent SSR, with a sperm retrieval rate of
two out of three.
KS is the most common chromosomal abnormality
occurring in about one in 580 newborn males, and has
non-mosaic (47, XXY) and mosaic (47, XXY/ 46, XY)
forms. Although previously believed to be sterile,
8.3% of patients with KS have sperm in their ejaculate
[31]. Whilst spontaneous pregnancy has been reported
in extremely rare occasions of KS, ICSI is perhaps the
more realistic approach through which pregnancy might
Table 5 Sperm retrieval rate in different chromosomal abnormalities.
Genetic abnormality Patients who
underwent ICSI, n
Sperm retrieved
from semen, n by SSR, n/N (%)
KS 19 0 6/19 (31.6)
Translocation
Robertsonian 4 2 1/2
Reciprocal 5 0 4/5
Others
Mos 45X [7]/46XY [43] 1 0 1/1
MOS 47XY (Marker 11)/46XY (Marker 10) 1 0 0
46XY, Inv(9)(p13; q21.1) 1 0 0
YCMD
Absent B and C 2 0 0
Absent C 5 2 2/3
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be achieved. Few cases of successful pregnancies have
been reported after ICSI with ejaculated sperm from
patients with KS [24]. Despite this, most patients present
with azoospermia and would require a sperm retrieval
procedure before ICSI. TESE use in patients with KS
yielded encouraging results with a sperm retrieval rate
ranging from 30% to 70% [19]. Almost half of all pub-
lished cases of patients with KS in whom TESE and
ICSI were performed achieved pregnancy and live births
[32]. Most of our present patients with KS (94.7%) pre-
sented with azoospermia and all of them required TESE,
where sperm were retrieved from 31.6% of patients
undergoing microsurgical TESE. Pregnancy was
achieved in half of the TESE-positive cases (three of six).
Chromosomal translocations occur in 0.08–0.3% of
the general population [33], and involve the transfer of
genetic material from one chromosome to another. This
can happen due to breakage of two non-homologous
chromosomes with exchange of segments (reciprocal),
or due to breakpoints occurring close to the centromere
of two acrocentric chromosomes (Robertsonian). The
translocations can result in a variety of sperm produc-
tion phenotypes from normal spermatogenesis to an
inability to produce spermatogonia [4]. Many of these
translocations are identified after recurrent spontaneous
abortions following ICSI [25]. In all, 12 of our present
infertile patients had chromosomal translocation, and
sperm was found in the ejaculate of two patients, whilst
we performed SSR for seven patients. The sperm were
retrieved in one of two patients with Robertsonian
translocations and four of five with reciprocal
translocations.
In the present study, of our 47 patients who had ICSI,
pregnancy was achieved in 25.7%. Both total sperm
retrieval rate and pregnancy outcome were significantly
lower amongst our infertile patients with chromosomal
abnormalities in comparison to those with idiopathic
infertility. This observation, which is in agreement with
a number of studies [34], can be explained by the higher
rate of sperm aneuploidy often found with such chromo-
somal abnormalities resulting in worse embryo quality,
implantation failure, and recurrent pregnancy loss [34].
Furthermore, the higher risk of transmission of reduced
fertility due to chromosomal abnormalities to the off-
spring necessitates thorough patient counselling and
use of pre-implantation genetic diagnosis prior to ICSI.
A limitation of the present research is that it is a sin-
gle fertility centre study, although single centre studies
are not uncommon in the literature [10,19–21]. How-
ever, our institution is the main male fertility unit in
Qatar (a country with small population) and covers
>80% of all infertility cases across the country. The
present study’s retrospective nature has the attending
limitation of incomplete data; however, retrospective
studies are also not uncommon in this type of research
[8,9]. Nevertheless, our hospital has a well updated
patient database that restricts and minimises the possi-
bility of incomplete data. Another limitation of the pre-
sent study is that next generation DNA sequencing was
not used to detect other genetic mutations that could not
be detected by karyotyping or PCR; however, this tech-
nology is still new and is basically used for research and
its incorporation in the clinical practice has not yet been
globalised.
Conclusion
The incidence of chromosomal abnormalities as a cause
of severe male infertility in the State of Qatar, as an
example of Eastern Mediterranean countries, is within
a similar range as their incidence internationally. Chro-
mosomal abnormalities affect the hormonal status of the
patients, with significant increases in the FSH and LH
levels, endowing more deleterious effects on spermato-
genesis, which was reflected by the lower sperm retrieval
rate and clinical pregnancy rates reported in patients
with chromosomal abnormalities compared to patients
with idiopathic infertility. Therefore, the negative prog-
nostic effects of chromosomal abnormalities on sperm
retrieval rate and ICSI outcomes should be clearly
explained to these patients during counselling for
in vitro fertilisation treatment. Future studies are defi-
nitely required to identify any new genetic abnormalities
and assist in deeper understandings of the causes of male
infertility. Higher rates of genetic abnormalities may be
found by searching for different genetic causes, e.g.
point mutations (single nucleotide substitutions), and
smaller deletions and duplications, which currently fall
below the threshold of detection of karyotyping.
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